Leung CON - Search Results

1

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK. Leung HW, et al. Among authors: leung con. Cancer Res. 2021 Jun 15;81(12):3229-3240. doi: 10.1158/0008-5472.CAN-21-0184. Epub 2021 Apr 26. Cancer Res. 2021. PMID: 33903122

2

PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma.

Leung CO, Wong CC, Fan DN, Kai AK, Tung EK, Xu IM, Ng IO, Lo RC. Leung CO, et al. Oncotarget. 2015 May 10;6(13):10880-92. doi: 10.18632/oncotarget.3534. Oncotarget. 2015. PMID: 25834102 Free PMC article.

3

Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling.

Leung CO, Mak WN, Kai AK, Chan KS, Lee TK, Ng IO, Lo RC. Leung CO, et al. Oncotarget. 2016 May 17;7(20):29371-86. doi: 10.18632/oncotarget.8835. Oncotarget. 2016. PMID: 27105493 Free PMC article.

4

Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.

Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC. Chan KK, et al. Cancer Lett. 2017 Sep 10;403:330-338. doi: 10.1016/j.canlet.2017.06.034. Epub 2017 Jul 6. Cancer Lett. 2017. PMID: 28688970

5

Variation of stemness markers expression in tumor nodules from synchronous multi-focal hepatocellular carcinoma - an immunohistochemical study.

Lo RC, Leung CO, Chok KS, Ng IO. Lo RC, et al. Diagn Pathol. 2017 Aug 1;12(1):56. doi: 10.1186/s13000-017-0649-9. Diagn Pathol. 2017. PMID: 28764740 Free PMC article. Clinical Trial.

6

Expression of hepatic progenitor cell markers in acute cellular rejection of liver allografts-An immunohistochemical study.

Lo RC, Chan KK, Leung CO, Ng IO. Lo RC, et al. Clin Transplant. 2018 Mar;32(3):e13203. doi: 10.1111/ctr.13203. Epub 2018 Feb 2. Clin Transplant. 2018. PMID: 29345755 Clinical Trial.

7

Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.

Lo RC, Leung CO, Chan KK, Ho DW, Wong CM, Lee TK, Ng IO. Lo RC, et al. Cell Death Differ. 2018 Aug;25(8):1426-1441. doi: 10.1038/s41418-018-0059-x. Epub 2018 Feb 14. Cell Death Differ. 2018. PMID: 29445127 Free PMC article.

8

IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.

Cheng BY, Lau EY, Leung HW, Leung CO, Ho NP, Gurung S, Cheng LK, Lin CH, Lo RC, Ma S, Ng IO, Lee TK. Cheng BY, et al. Cancer Res. 2018 May 1;78(9):2332-2342. doi: 10.1158/0008-5472.CAN-17-2445. Epub 2018 Feb 26. Cancer Res. 2018. PMID: 29483095

9

Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.

Tan HW, Leung CO, Chan KK, Ho DW, Leung MS, Wong CM, Ng IO, Lo RC. Tan HW, et al. Int J Cancer. 2019 Oct 1;145(7):1860-1873. doi: 10.1002/ijc.32248. Epub 2019 Mar 28. Int J Cancer. 2019. PMID: 30834518

10

Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain-Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma.

Leung CON, Tong M, Chung KPS, Zhou L, Che N, Tang KH, Ding J, Lau EYT, Ng IOL, Ma S, Lee TKW. Leung CON, et al. Hepatology. 2020 Jul;72(1):155-168. doi: 10.1002/hep.30989. Epub 2020 Mar 31. Hepatology. 2020. PMID: 31610028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters